---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-007958"
form_type: "8-K"
ticker: "CAPR"
cik: "0001133869"
company_name: "CAPRICOR THERAPEUTICS, INC."
filed_at: "2024-05-13T23:59:59+00:00"
generated_at: "2026-06-02T01:54:32.119121+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Capricor Q1 net loss $9.8M; HOPE-3 Cohort A fully enrolled for Q4 data

## Summary
- Net loss $9.8M ($0.31/share) vs $7.8M loss prior year; revenue $4.9M from Nippon Shinyaku milestone.
- Phase 3 HOPE-3 Cohort A fully enrolled (61 patients); top-line results expected Q4 2024.
- Positive Type-B CMC FDA meeting confirmed manufacturing comparability between facilities.
- Received $10M milestone from Nippon Shinyaku; $90M pre-approval milestones remain possible.
- Cash $39.9M stable; runway into Q1 2025, excluding additional milestones.

## SEC filing metadata
- accession: 0001558370-24-007958
- form_type: 8-K
- ticker: CAPR
- cik: 0001133869
- company_name: CAPRICOR THERAPEUTICS, INC.
- filed_at: 2024-05-13T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133869/000155837024007958/0001558370-24-007958-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133869/000155837024007958/capr-20240513x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-007958
- JSON: https://secwatch.observer/filing/0001558370-24-007958.json
- Plain text: https://secwatch.observer/filing/0001558370-24-007958.txt

## Key facts
- Earnings Releases
  CAPRICOR THERAPEUTICS, INC. reported financial results for first quarter ended March 31, 2024.
  - Period: first quarter ended March 31, 2024
  - Result: reported results
  source text: On May 13, 2024, Capricor Therapeutics, Inc., a Delaware corporation (the “Company”), issued a press release announcing its financial results for the quarter ended March 31, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1133869/000155837024007958/0001558370-24-007958-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.